Join us for our quarterly meeting, available to all SCC members. Ziva Cooper, PhD is the featured speaker who will discuss “Controlled Human Laboratory Studies of Cannabis and Cannabinoids: Probing Current Trends in Medicinal Cannabis”.
Dr. Ziva Cooper is the Interim Director and Research Director of the UCLA Cannabis Research Initiative in the Jane and Terry Semel Institute and Associate Professor in the Department of Psychiatry. Her research involves understanding variables that influence both the therapeutic potential and adverse effects of cannabis and cannabinoids. Dr. Cooper received her PhD from the University of Michigan in Biopsychology in 2007 in the field of preclinical psychopharmacology, experience that informs her focus on translating preclinical studies of cannabinoids to the clinic using controlled human drug-administration studies. Current projects include understanding differences between men and women in their response to the pain-relieving effects of cannabis, the potential for cannabis constituents to reduce reliance on opioids, and therapeutic effects of cannabinoids in patient populations. Dr. Cooper served on the National Academies of Sciences Committee on the Health Effects of Cannabis that recently published a comprehensive report of the health effects of cannabis and cannabinoids. She is a Board Director for the College on Problems of Drug Dependence, an Associate Editor of The American Journal of Drug and Alcohol Abuse, and is on several Editorial Boards of journals including Cannabis and Cannabinoid Research and Neuropsychopharmacology.
The meeting is remote and available to all SCC members. Members can log in to the membership portal for instructions on how to join.
